Skip to main content
. 2022 May 11;23(10):5351. doi: 10.3390/ijms23105351

Figure 5.

Figure 5

Targeted therapies for malignant glioma. Simplified representation of (A) tyrosine kinase receptor inhibitors, (B) IDH, gene fusion and MCT inhibitors and (C) specific inhibitors of intracellular downstream pathways. Figure drawn with smart.servier.com.